Well, anything in the cell & gene therapy space, in theory, but it really depends on the therapy in question, and even that might not be a problem because Orgenesis argues they are doing things cheaper.

My pleasure Alexa. It's a pretty complex company, perhaps it's more like a little network, as it happens.

Yes, it's like a mini-conglomerate

Yep, that's possible Adam, it's interesting tech which does good in medical appliances, but as with much tech, in the wrong hands it can do damage..

Yep, they have some interesting technology which is applicable in numerous situations.

Will let you know what they answered ASAP.

I'm not sure what the hold-up is, as puzzled as the commentators but I've contacted the company, stay tuned..

It's difficult to value FitPay at the moment but LogicMark without having to finance the finance business looks pretty good to us on a valuation basis.

There's not really much we can do about that Dan..

Thanks Dick, my pleasure